Aminoacyl-Transfer RNA Synthetase Deficiency Promotes Angiogenesis via the Unfolded Protein Response Pathway

Daniel Castranova1, Andrew E Davis1, Brigid D Lo1

  • 1From the Program in Genomics of Differentiation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD (D.C., A.E.D., B.D.L., M.F.M., M.R.S., V.N.P., J.T.-V., K.B., K.M.S., M.K., B.M.W.); and Department of Chemistry and Biochemistry, College of Computer, Mathematical, and Natural Sciences, University of Maryland, College Park (P.J.P.).

Abstract

Insights

Mutations in aminoacyl-transfer RNA synthetases cause increased blood vessel formation (angiogenesis) in zebrafish by activating the unfolded protein response pathway and upregulating vascular endothelial growth factor.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for development and disease.
  • Understanding the molecular regulators of angiogenesis is vital for therapeutic interventions.

Purpose of the Study:

  • To investigate the role of aminoacyl-transfer RNA synthetases in angiogenesis.
  • To elucidate the molecular mechanisms linking these enzymes to blood vessel formation.

Main Methods:

  • Utilized zebrafish (Danio rerio) as a model organism.
  • Generated and analyzed mutations in threonyl tRNA synthetase (tars) and isoleucyl tRNA synthetase (iars) genes.
  • Assessed angiogenesis, unfolded protein response (UPR) gene expression, and vascular endothelial growth factor (VEGF) levels.

Main Results:

  • Mutations in tars and iars led to significantly increased angiogenesis in zebrafish.
  • Aminoacyl-transfer RNA synthetase deficiencies activated the UPR pathway, upregulating UPR genes (atf4, atf6, xbp1).
  • Vascular endothelial growth factor A (vegfaa) was upregulated in mutants, and the activating transcription factor 4 (ATF4) arm of the UPR was essential for elevated vegfaa and angiogenesis.

Conclusions:

  • Endoplasmic reticulum (ER) stress, triggered by aminoacyl-transfer RNA synthetase dysfunction, acts as a proangiogenic signal.
  • The UPR pathway mediates this effect through the upregulation of vegfaa.
  • These findings reveal a novel link between protein synthesis machinery and angiogenic signaling.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K